Postcricoid region cancer is a malignant neoplasm involving the postcricoid portion of the hypopharynx at the pharyngoesophageal junction. Most primary tumors in this region are managed clinically as hypopharyngeal head and neck cancers, commonly with squamous differentiation, and can cause dysphagia, voice change, airway compromise, and cervical nodal or distant metastatic disease.
Ask a research question about Postcricoid Region Cancer. OpenScientist will conduct autonomous deep research using the Disorder Mechanisms Knowledge Base and PubMed literature (typically 10-30 minutes).
Do not include personal health information in your question. Questions and results are cached in your browser's local storage.
name: Postcricoid Region Cancer
creation_date: "2026-05-10T20:10:37Z"
updated_date: "2026-05-10T22:20:00Z"
description: >-
Postcricoid region cancer is a malignant neoplasm involving the postcricoid
portion of the hypopharynx at the pharyngoesophageal junction. Most primary
tumors in this region are managed clinically as hypopharyngeal head and neck
cancers, commonly with squamous differentiation, and can cause dysphagia,
voice change, airway compromise, and cervical nodal or distant metastatic
disease.
category: Cancer
categories:
- Head and Neck Cancer
- Hypopharyngeal Cancer
- Solid Tumor
- Squamous Cell Carcinoma
synonyms:
- postcricoid carcinoma
- post-cricoid carcinoma
- postcricoid hypopharyngeal carcinoma
- postcricoid hypopharyngeal squamous cell carcinoma
disease_term:
preferred_term: postcricoid region cancer
term:
id: MONDO:0004635
label: postcricoid region cancer
parents:
- hypopharynx cancer
- head and neck cancer
prevalence:
- population: Global hypopharyngeal cancer burden
notes: >-
Postcricoid tumors are an uncommon anatomic subsite within hypopharyngeal
cancer. Global epidemiology is generally reported for hypopharyngeal cancer
as a group rather than for the postcricoid subsite alone.
evidence:
- reference: PMID:39286014
reference_title: "Global epidemiology and socioeconomic correlates of hypopharyngeal cancer in 2020 and its projection to 2040: findings from GLOBOCAN 2020."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Hypopharyngeal cancer (HC) comprises less than 5% of all malignant tumors
in the head and neck.
explanation: >-
This GLOBOCAN analysis supports the rarity of hypopharyngeal cancer
relative to other head and neck malignancies.
- reference: PMID:39286014
reference_title: "Global epidemiology and socioeconomic correlates of hypopharyngeal cancer in 2020 and its projection to 2040: findings from GLOBOCAN 2020."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "In 2020, there were 84254 new HC cases globally (ASIR: 0.91 per 100000)."
explanation: >-
Provides a recent global incidence estimate for the broader hypopharyngeal
cancer group that includes postcricoid tumors.
progression:
- phase: Often advanced at detection
notes: >-
The postcricoid subsite may remain clinically occult until dysphagia, voice
change, airway compromise, nodal disease, or distant disease prompts
evaluation.
evidence:
- reference: PMID:39286014
reference_title: "Global epidemiology and socioeconomic correlates of hypopharyngeal cancer in 2020 and its projection to 2040: findings from GLOBOCAN 2020."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
They often present at an advanced stage, thereby resulting in high
mortalities.
explanation: >-
The broader hypopharyngeal cancer epidemiology supports late presentation
as a key clinical behavior.
- reference: PMID:38719981
reference_title: "Early-stage hypopharyngeal squamous cell carcinoma treated with radical radiotherapy at a uniform dose of 70 Gy in 35 fractions: a single-center study."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Hypopharyngeal squamous cell carcinoma (HSCC) is often undetected until
advanced stages, which contributes to poor survival rates.
explanation: >-
This early-stage treatment cohort explicitly notes the common detection
delay for hypopharyngeal SCC.
environmental:
- name: Tobacco and alcohol exposure
description: >-
Tobacco and alcohol exposure are established risk factors across head and
neck squamous cell carcinomas and are relevant to hypopharyngeal/postcricoid
squamous carcinogenesis, although individual postcricoid-subsite risk
estimates are limited.
exposure_term:
preferred_term: exposure to tobacco smoking
term:
id: ECTO:6000029
label: exposure to tobacco smoking
evidence:
- reference: PMID:39219259
reference_title: Epithelial-derived head and neck squamous tumourigenesis (Review).
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Several factors, including smoking, alcohol consumption, oncogenic genes,
growth factors, Epstein-Barr virus and human papillomavirus infections can
contribute to HNSCC development.
explanation: >-
Supports tobacco and alcohol as major environmental contributors in the
broader head and neck squamous cancer family that includes hypopharyngeal
SCC.
- name: Plummer-Vinson Syndrome Risk Context
description: >-
Plummer-Vinson syndrome, with iron deficiency anemia, dysphagia, and upper
esophageal or postcricoid webs, is a recognized premalignant context for
hypopharyngeal and upper esophageal squamous cancers.
evidence:
- reference: PMID:31417270
reference_title: "Plummer-Vinson syndrome: improving outcomes with a multidisciplinary approach."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
It is also important to recognize the association of Plummer-Vinson
Syndrome with esophageal and hypopharyngeal cancer.
explanation: >-
Supports Plummer-Vinson syndrome as a clinically relevant risk context for
hypopharyngeal/postcricoid squamous carcinoma.
pathophysiology:
- name: Malignant Transformation of Postcricoid Squamous Epithelium
description: >-
Squamous epithelial cells in the postcricoid hypopharynx undergo malignant
transformation, with increased proliferation and acquisition of invasive
behavior.
cell_types:
- preferred_term: squamous epithelial cell
term:
id: CL:0000076
label: squamous epithelial cell
locations:
- preferred_term: hypopharynx
term:
id: UBERON:0001051
label: hypopharynx
biological_processes:
- preferred_term: DNA damage response
modifier: ABNORMAL
term:
id: GO:0006974
label: DNA damage response
- preferred_term: cell population proliferation
modifier: INCREASED
term:
id: GO:0008283
label: cell population proliferation
downstream:
- target: Local Invasion and Metastatic Spread
description: >-
Transformed squamous cells invade the hypopharyngeal wall and can spread
to regional lymph nodes or distant sites.
evidence:
- reference: DOI:10.1055/s-0042-1759504
reference_title: "Imaging Recommendations for Diagnosis, Staging and Management of Larynx and Hypopharynx Cancer"
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Squamous cell carcinoma is the most common histological type."
explanation: >-
Supports squamous epithelial malignant transformation as the dominant
histologic pattern for hypopharyngeal cancers.
- name: Local Invasion and Metastatic Spread
description: >-
Tumor extension through the hypopharyngeal wall and spread to nodal or
distant sites drives staging, prognosis, and multimodality treatment
selection.
locations:
- preferred_term: hypopharynx
term:
id: UBERON:0001051
label: hypopharynx
biological_processes:
- preferred_term: cell migration
modifier: INCREASED
term:
id: GO:0016477
label: cell migration
downstream:
- target: Dysphagia
description: Local mass effect and impaired hypopharyngeal transit produce swallowing difficulty.
- target: Airway and Voice Dysfunction
description: Local extension can involve laryngeal function, vocal fold motion, and airway patency.
- target: Adaptive Immune Resistance
description: >-
Progressing squamous tumors can acquire immune-evasion programs that are
relevant to checkpoint inhibitor treatment selection.
evidence:
- reference: DOI:10.1055/s-0042-1759504
reference_title: "Imaging Recommendations for Diagnosis, Staging and Management of Larynx and Hypopharynx Cancer"
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Imaging also plays a major role in its staging, including local disease
extent, nodal and distant metastatic status, as well as to assess response
to therapy.
explanation: >-
Supports local extension, nodal spread, and distant metastatic status as
core hypopharyngeal cancer disease behaviors.
- reference: DOI:10.3390/jpm14101048
reference_title: Personalized Treatment Strategies via Integration of Gene Expression Biomarkers in Molecular Profiling of Laryngeal Cancer
supports: PARTIAL
evidence_source: OTHER
snippet: >-
The review focuses on indicators, including PD-L1, CTLA-4, and tumor
mutational burden (TMB) in predicting immunotherapy responses, highlighting
recent developments in our understanding of the intricate interactions
between tumor genetics and the immune milieu.
explanation: >-
This broader laryngeal/head-and-neck squamous cancer review supports
checkpoint-relevant immune biology as a treatment-selection mechanism near
the hypopharyngeal/postcricoid disease space.
- name: Adaptive Immune Resistance
conforms_to: "immune_checkpoint_blockade#Adaptive Immune Resistance"
description: >-
Postcricoid and hypopharyngeal squamous tumors can be treated with PD-1
pathway blockade in chemoimmunotherapy protocols, reflecting checkpoint-
mediated suppression of antitumor T-cell activity rather than direct targeting
of invasion alone.
biological_processes:
- preferred_term: negative regulation of T cell mediated immunity
modifier: INCREASED
term:
id: GO:0002710
label: negative regulation of T cell mediated immunity
downstream:
- target: T Cell Exhaustion and Immune Escape
description: >-
Persistent checkpoint engagement suppresses cytotoxic T-cell function and
supports tumor immune escape.
evidence:
- reference: PMID:38762484
reference_title: "PD-1/PD-L1 axis in cancer: Regulatory mechanisms and therapeutic targets."
supports: SUPPORT
evidence_source: OTHER
snippet: >-
However, cancer cells exploit the PD-1/PD-L1 axis to cause immune escape in
cancer development and progression.
explanation: >-
Supports PD-1/PD-L1 axis exploitation as an adaptive immune resistance
mechanism across cancers.
- reference: DOI:10.3390/jpm14101048
reference_title: Personalized Treatment Strategies via Integration of Gene Expression Biomarkers in Molecular Profiling of Laryngeal Cancer
supports: PARTIAL
evidence_source: OTHER
snippet: >-
The review focuses on indicators, including PD-L1, CTLA-4, and tumor
mutational burden (TMB) in predicting immunotherapy responses, highlighting
recent developments in our understanding of the intricate interactions
between tumor genetics and the immune milieu.
explanation: >-
Supports checkpoint-relevant immune biomarkers in an adjacent head-and-neck
squamous cancer setting; applied conservatively because it is not
postcricoid-subsite specific.
- name: T Cell Exhaustion and Immune Escape
conforms_to: "immune_checkpoint_blockade#T Cell Exhaustion and Immune Escape"
description: >-
Suppressed tumor-infiltrating T cells can lose effective cytokine production
and cytolytic activity, allowing immune escape within the tumor
microenvironment.
cell_types:
- preferred_term: exhausted T cell
term:
id: CL:0011025
label: exhausted T cell
biological_processes:
- preferred_term: exhausted T cell differentiation
modifier: INCREASED
term:
id: GO:0160083
label: exhausted T cell differentiation
evidence:
- reference: PMID:26086965
reference_title: T-cell exhaustion in the tumor microenvironment.
supports: SUPPORT
evidence_source: OTHER
snippet: >-
The exhausted T cells in the tumor microenvironment show overexpressed
inhibitory receptors, decreased effector cytokine production and cytolytic
activity, leading to the failure of cancer elimination.
explanation: >-
Supports exhausted T-cell immune escape as a downstream checkpoint-related
tumor microenvironment state.
histopathology:
- name: Squamous Cell Carcinoma
finding_term:
preferred_term: Squamous Cell Carcinoma
term:
id: NCIT:C2929
label: Squamous Cell Carcinoma
frequency: VERY_FREQUENT
diagnostic: true
description: >-
Squamous cell carcinoma is the dominant histologic type for hypopharyngeal
cancers and is the expected histology for most postcricoid primary tumors.
evidence:
- reference: DOI:10.1055/s-0042-1759504
reference_title: "Imaging Recommendations for Diagnosis, Staging and Management of Larynx and Hypopharynx Cancer"
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Squamous cell carcinoma is the most common histological type."
explanation: >-
Directly supports squamous carcinoma as the common histology in
hypopharyngeal cancer.
phenotypes:
- category: Head and Neck
name: Dysphagia
frequency: FREQUENT
diagnostic: true
description: >-
Difficulty swallowing is a common presenting symptom because the tumor
occupies the postcricoid hypopharynx near the pharyngoesophageal junction.
phenotype_term:
preferred_term: Dysphagia
term:
id: HP:0002015
label: Dysphagia
evidence:
- reference: PMID:38711727
reference_title: "Clinical Conundrum: Unveiling a Unique Presentation of Hypopharyngeal Carcinoma."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
A 33-year-old female presented at a tertiary care hospital in Western
India with hoarseness of voice, difficulty in swallowing, productive
cough, and neck pain for two months with an abrupt increase in the
severity of all symptoms in two days.
explanation: >-
This post-cricoid growth case directly supports dysphagia as a presenting
manifestation.
- category: Head and Neck
name: Hoarse Voice
frequency: FREQUENT
description: >-
Hoarseness can reflect local tumor extension, vocal cord paresis, or
associated laryngeal involvement.
phenotype_term:
preferred_term: Hoarse voice
term:
id: HP:0001609
label: Hoarse voice
evidence:
- reference: PMID:19078805
reference_title: Postcricoid pharyngeal carcinoma mimicking bulbar amyotrophic lateral sclerosis.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
This report describes a 73-year-old man who had a 10-month history of
progressive hoarseness, dysphagia, and respiratory failure.
explanation: >-
This postcricoid carcinoma case supports hoarseness and swallowing
symptoms as presenting features.
- category: Respiratory
name: Respiratory Failure or Airway Compromise
frequency: OCCASIONAL
description: >-
Advanced local disease can compromise the airway directly or through vocal
cord paralysis.
phenotype_term:
preferred_term: Respiratory insufficiency
term:
id: HP:0002093
label: Respiratory insufficiency
evidence:
- reference: PMID:19078805
reference_title: Postcricoid pharyngeal carcinoma mimicking bulbar amyotrophic lateral sclerosis.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Computed tomography of his neck identified a postcricoid squamous cell
carcinoma, which was causing bilateral vocal cord paralysis.
explanation: >-
Supports airway and vocal cord involvement as a severe manifestation of
postcricoid carcinoma.
- category: Constitutional
name: Anemia in Plummer-Vinson Syndrome Risk Context
frequency: OCCASIONAL
description: >-
Iron deficiency anemia is not a tumor manifestation by itself, but it is a
key feature of Plummer-Vinson syndrome, a premalignant context for
hypopharyngeal and upper esophageal squamous carcinoma.
phenotype_term:
preferred_term: Anemia
term:
id: HP:0001903
label: Anemia
evidence:
- reference: PMID:31417270
reference_title: "Plummer-Vinson syndrome: improving outcomes with a multidisciplinary approach."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Plummer-Vinson syndrome is a rare condition associated with dysphagia,
iron deficiency, and esophageal webs.
explanation: >-
Supports anemia/iron deficiency as part of the postcricoid-relevant
Plummer-Vinson risk context.
genetic:
- name: Somatic head and neck squamous carcinoma alterations
relationship_type: SUSCEPTIBILITY
notes: >-
Postcricoid-specific molecular series are limited. Broader head and neck
squamous carcinoma literature supports recurrent somatic alterations and
pathway disruption involving tumor suppressor, growth factor, and immune
evasion programs.
evidence:
- reference: PMID:39219259
reference_title: Epithelial-derived head and neck squamous tumourigenesis (Review).
supports: PARTIAL
evidence_source: HUMAN_CLINICAL
snippet: >-
Comprehensive genomic, transcriptomic, metabolomic, microbiome and
proteomic analyses allow researchers to identify important biological
markers such as genetic alterations, gene expression signatures and
protein markers that drive HNSCC tumours.
explanation: >-
Supports molecular alteration as relevant in the broader HNSCC family;
the assertion is deliberately broad because the cited evidence is not
postcricoid-subsite specific.
- name: TP53 alteration in head and neck squamous carcinoma
gene_term:
preferred_term: TP53
term:
id: hgnc:11998
label: TP53
relationship_type: SUSCEPTIBILITY
notes: >-
TP53 alteration is a major somatic feature of smoking-related and
HPV-negative head and neck squamous cell carcinoma. This is included as
broader HNSCC context rather than as a postcricoid-subsite-specific
molecular frequency.
evidence:
- reference: PMID:25631445
reference_title: Comprehensive genomic characterization of head and neck squamous cell carcinomas.
supports: PARTIAL
evidence_source: HUMAN_CLINICAL
snippet: >-
Smoking-related HNSCCs demonstrate near universal loss-of-function TP53
mutations and CDKN2A inactivation with frequent copy number alterations
including amplification of 3q26/28 and 11q13/22.
explanation: >-
Supports TP53 as a major altered gene in broader HNSCC; marked PARTIAL
because the TCGA cohort is not specific to the postcricoid subsite.
diagnosis:
- name: Endoscopic Examination and Biopsy
description: >-
Endoscopy is used for direct mucosal evaluation, staging, and biopsy
confirmation of suspected postcricoid or hypopharyngeal lesions.
diagnosis_term:
preferred_term: diagnostic procedure
term:
id: MAXO:0000003
label: diagnostic procedure
evidence:
- reference: DOI:10.1055/s-0042-1759504
reference_title: "Imaging Recommendations for Diagnosis, Staging and Management of Larynx and Hypopharynx Cancer"
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Clinical examination and endoscopy play an integral role in its detection
and staging.
explanation: >-
Supports endoscopy as a core diagnostic and staging procedure for
hypopharyngeal cancer.
- reference: PMID:38711727
reference_title: "Clinical Conundrum: Unveiling a Unique Presentation of Hypopharyngeal Carcinoma."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Squamous cell carcinoma was confirmed on the biopsy report."
explanation: >-
Supports biopsy confirmation in a case with post-cricoid growth.
- name: Imaging for Local, Nodal, and Distant Staging
description: >-
Cross-sectional imaging defines local extent, nodal involvement, distant
metastatic status, treatment response, and recurrence versus post-treatment
change.
diagnosis_term:
preferred_term: computed tomography
term:
id: NCIT:C17204
label: Computed Tomography
evidence:
- reference: DOI:10.1055/s-0042-1759504
reference_title: "Imaging Recommendations for Diagnosis, Staging and Management of Larynx and Hypopharynx Cancer"
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Imaging also plays a major role in its staging, including local disease
extent, nodal and distant metastatic status, as well as to assess response
to therapy.
explanation: >-
Supports imaging for staging and treatment-response assessment in
hypopharyngeal cancer.
treatments:
- name: Radical Radiotherapy for Early-Stage Hypopharyngeal SCC
description: >-
Organ-preserving radiotherapy is an evidence-supported option for selected
early-stage hypopharyngeal SCC, including small postcricoid-region subsets.
treatment_term:
preferred_term: radiation therapy
term:
id: MAXO:0000014
label: radiation therapy
target_mechanisms:
- target: Malignant Transformation of Postcricoid Squamous Epithelium
treatment_effect: INHIBITS
description: >-
Definitive radiotherapy targets proliferating malignant squamous tumor
cells at the primary site.
evidence:
- reference: PMID:38719981
reference_title: "Early-stage hypopharyngeal squamous cell carcinoma treated with radical radiotherapy at a uniform dose of 70 Gy in 35 fractions: a single-center study."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
This study supports radical radiotherapy as an effective approach for
optimal tumor control in patients with early stage HSCC.
explanation: >-
Supports radical radiotherapy as an organ-preserving option for
early-stage hypopharyngeal SCC.
- name: Surgery-Based Therapy for Resectable Hypopharyngeal Carcinoma
description: >-
Surgery-based therapy, often followed by adjuvant radiotherapy with or
without chemotherapy depending on stage and risk features, is used for
resectable hypopharyngeal/postcricoid disease.
treatment_term:
preferred_term: surgical procedure
term:
id: MAXO:0000004
label: surgical procedure
target_mechanisms:
- target: Local Invasion and Metastatic Spread
treatment_effect: INHIBITS
description: >-
Resection removes locally invasive tumor, with adjuvant therapy selected
for residual local, nodal, or metastatic risk.
evidence:
- reference: PMID:36937435
reference_title: Survival analyses of different treatment modalities and clinical stage for hypopharyngeal carcinoma.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
SBT can obtain significant survival benefits when compared with definitive
CRT for the whole cohort of patients.
explanation: >-
Supports surgery-based therapy as an important treatment modality for
hypopharyngeal carcinoma.
- reference: DOI:10.1055/s-0042-1759504
reference_title: "Imaging Recommendations for Diagnosis, Staging and Management of Larynx and Hypopharynx Cancer"
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Advanced disease is treated with multimodality of either chemoradiotherapy
or surgery followed by adjuvant radiotherapy with or without concurrent
chemotherapy.
explanation: >-
Supports multimodality treatment for advanced hypopharyngeal cancer.
- name: Induction Chemoimmunotherapy for Locally Advanced Hypopharyngeal SCC
description: >-
Phase II data support induction camrelizumab plus modified TPF as an
emerging organ-preservation strategy for locally advanced hypopharyngeal
squamous cell carcinoma, with surgery and adjuvant treatment reserved for
non-responders in the studied protocol.
treatment_term:
preferred_term: pharmacotherapy
term:
id: MAXO:0000058
label: pharmacotherapy
therapeutic_agent:
- preferred_term: camrelizumab
- preferred_term: docetaxel
- preferred_term: cisplatin
term:
id: CHEBI:27899
label: cisplatin
- preferred_term: capecitabine
term:
id: CHEBI:31348
label: capecitabine
target_mechanisms:
- target: Adaptive Immune Resistance
treatment_effect: INHIBITS
description: >-
Camrelizumab-containing induction therapy includes PD-1 pathway blockade,
linking this regimen to checkpoint-mediated immune escape rather than to
local invasion alone.
- target: Local Invasion and Metastatic Spread
treatment_effect: MODULATES
description: >-
The combined chemotherapy and immunotherapy regimen aims to shrink locally
advanced tumor and select patients for organ-preserving therapy versus
surgery.
evidence:
- reference: PMID:38898018
reference_title: "Camrelizumab-based induction chemoimmunotherapy in locally advanced stage hypopharyngeal carcinoma: phase II clinical trial."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
This phase II trial aimed to determine the efficacy and safety of
induction chemoimmunotherapy of camrelizumab plus modified TPF in locally
advanced hypopharyngeal squamous cell carcinoma (LA HSCC) (NCT04156698).
explanation: >-
Supports chemoimmunotherapy as an emerging treatment strategy for locally
advanced hypopharyngeal SCC.
- reference: PMID:38898018
reference_title: "Camrelizumab-based induction chemoimmunotherapy in locally advanced stage hypopharyngeal carcinoma: phase II clinical trial."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
After induction therapy, the ORR was 82.4% (42/51), meeting the
prespecified endpoint.
explanation: >-
Provides trial outcome evidence for response after induction
chemoimmunotherapy.
clinical_trials:
- name: NCT04156698
phase: PHASE_II
status: UNKNOWN
description: >-
Single-center, open-label phase 2 study of induction camrelizumab plus
modified TPF chemoimmunotherapy for locally advanced hypopharyngeal
carcinoma.
evidence:
- reference: clinicaltrials:NCT04156698
reference_title: A Phase II, Single-center, Open-label, Single-arm Study of Induction Chemotherapy Combined With Immunotherapy for Locally Advanced Hypopharyngeal Carcinoma
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
This is a single-center, multidisciplinary, open-label, single-arm
prospective clinical study.
explanation: >-
Supports NCT04156698 as a directly relevant prospective phase 2
hypopharyngeal carcinoma trial.
- name: NCT06039631
phase: PHASE_II
status: UNKNOWN
description: >-
Trial of neoadjuvant immunotherapy plus chemotherapy followed by concurrent
radiochemotherapy or organ-preserving surgery for locally advanced
laryngeal and hypopharyngeal cancer.
evidence:
- reference: clinicaltrials:NCT06039631
reference_title: Neoadjuvant Immunotherapy And Chemotherapy Followed By Concurrent Chemoradiation Or Organ Preservation Surgery In Locally Advanced Laryngeal Cancer And Hypopharyngeal Cancer
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Against this backdrop, the current study aims to explore neoadjuvant
immunotherapy combined with chemotherapy for patients with locally
advanced laryngeal and hypopharyngeal cancer.
explanation: >-
Supports the trial as relevant to locally advanced hypopharyngeal cancer.
datasets: []
notes: >-
The initial page was created before Falcon deep research, then expanded using
the Falcon report and fetched reference caches. Mechanistic and molecular
assertions are conservative when the available evidence is for hypopharyngeal
cancer or broader head and neck squamous cell carcinoma rather than the
postcricoid subsite alone. Review follow-up added checkpoint-linked immune
evasion and TP53 context from broader head-and-neck squamous carcinoma
literature. Additional symptoms listed in the Falcon report, including
odynophagia, stridor, and otalgia, were not expanded here because the available
cached DOI abstract does not include directly quotable symptom text and the
suggested stridor HPO identifier resolves locally to an unrelated term.
Disease name: Postcricoid region cancer (most commonly postcricoid hypopharyngeal squamous cell carcinoma, a hypopharyngeal cancer subsite) (glastonbury2020headandneck pages 1-2, mousavi2024globalepidemiologyand pages 1-2).
Postcricoid region cancer is best conceptualized as a hypopharyngeal malignancy arising from the postcricoid region (anterior wall of the hypopharynx, overlying the posterior cricoid cartilage), most often squamous cell carcinoma (SCC). It is clinically important because (i) it is frequently advanced at diagnosis, (ii) it exhibits submucosal spread toward the cervical esophagus, and (iii) treatment requires balancing oncologic control with laryngo-esophageal function preservation (glastonbury2020headandneck pages 1-2, sahu2023imagingrecommendationsfor pages 5-8, katano2024earlystagehypopharyngealsquamous pages 1-2).
A concise evidence table of key recent quantitative findings is provided below.
| Topic | Key quantitative data | Key qualitative takeaway | Source (first author, year) | URL |
|---|---|---|---|---|
| Global epidemiology of hypopharyngeal cancer (includes postcricoid subsite) | 84,254 new cases globally in 2020; ASIR 0.91/100,000; 38,599 deaths; ASMR 0.41/100,000; MIR 0.45; projected increase by 2040: new cases +50%, deaths +55%; subsite distribution: ~70% pyriform sinus, ~25% posterior pharyngeal wall, remainder largely post-cricoid; HC is <5% of head and neck malignancies (mousavi2024globalepidemiologyand pages 1-2, mousavi2024globalepidemiologyand pages 2-3) | Postcricoid-region cancer is best understood as a rare hypopharyngeal cancer subsite within a high-mortality disease that is more common in men and often diagnosed late. | Mousavi, 2024 | https://doi.org/10.3389/fonc.2024.1398063 |
| Symptoms and NCCN diagnostic workup | Common symptoms: hoarseness, breathing difficulty, dysphagia/odynophagia, foreign-body sensation, ear ache; advanced signs include stridor/aspiration. NCCN-referenced workup: examination under anesthesia with endoscopy/biopsy; CECT and/or MRI of primary and neck; chest CT for advanced nodal disease/smokers; FDG PET-CT for stage III-IV disease (sahu2023imagingrecommendationsfor pages 1-2, sahu2023imagingrecommendationsfor pages 5-8, sahu2023imagingrecommendationsfor pages 2-3) | Endoscopy is essential for mucosal assessment and biopsy, but CT/MRI/PET are required to define submucosal spread, cartilage invasion, nodal disease, response, and recurrence in postcricoid tumors. | Sahu, 2023 | https://doi.org/10.1055/s-0042-1759504 |
| Radical radiotherapy outcomes for early-stage HSCC, including postcricoid subsite | Uniform RT: 70 Gy in 35 fractions to primary site plus elective nodal irradiation; 5-year OS 80.7% (95% CI 66.5-89.4%); 5-year DFS 66.4%; 5-year LRC 79.3%; postcricoid subsite 5-year OS 100% in this small series; no grade >=3 toxicities reported (katano2024earlystagehypopharyngealsquamous pages 1-2, katano2024earlystagehypopharyngealsquamous pages 2-5) | For stage I-II hypopharyngeal SCC, organ-preserving radical RT can produce strong long-term control with favorable toxicity; postcricoid outcomes were encouraging but based on very small numbers. | Katano, 2024 | https://doi.org/10.1007/s00405-024-08722-w |
| Surgery-based therapy vs definitive chemoradiotherapy in hypopharyngeal carcinoma | 167 patients; 5-year OS 59.7% with surgery-based therapy vs 24.0% with definitive CRT (p<0.0001); 5-year PFS 49.9% vs 22.6% (p=0.0002); surgery also improved LFFS, RFFS, DMFFS; survival similar between modalities mainly for T3 or stage III disease (lin2023survivalanalysesof pages 1-2, lin2023survivalanalysesof pages 2-3) | In retrospective data, surgery-based therapy often outperformed definitive CRT overall, but organ-preservation approaches may remain reasonable for selected T3/stage III cases. Extensive postcricoid/esophageal inlet involvement favored total laryngectomy/pharyngectomy. | Lin, 2023 | https://doi.org/10.3389/fonc.2023.1109417 |
| Plummer-Vinson syndrome (PVS) as a risk context for postcricoid/pharyngeal SCC | Reported malignancy incidence in PVS: 3-15% overall; one report cites post-cricoid carcinoma in ~4-16% across studies; yearly surveillance endoscopy is commonly suggested though no definitive guideline exists (patil2023endoscopicsubmucosaldissection pages 1-2, lo2019plummervinsonsyndromeimproving pages 5-6, patil2023endoscopicsubmucosaldissection pages 2-4, lo2019plummervinsonsyndromeimproving pages 2-3) | PVS (iron deficiency anemia + dysphagia + upper esophageal/post-cricoid web) is a classic premalignant association for postcricoid/pharyngeal SCC; long-term surveillance is generally recommended despite limited evidence and lack of standardized intervals. | Lo, 2019; Patil, 2023 | https://doi.org/10.2147/JMDH.S180410 ; https://doi.org/10.1055/s-0042-1759510 |
| Organ-preservation chemoimmunotherapy studies/trials | NCT04156698: phase II, n=51, camrelizumab + modified TPF; ORR 82.4% (42/51); 2-year OS 83.0%; 2-year PFS 77.1%; 2-year larynx preservation rate 70.0%. NCT06039631: randomized phase II, planned n=82; neoadjuvant chemoimmunotherapy followed by organ-preservation surgery vs concurrent chemoradiation; RT arm 70 Gy/35 fractions + weekly cisplatin; primary endpoint 2-year PFS; key secondary endpoints include larynx preservation, OS, QoL (NCT04156698 chunk 1, NCT06039631 chunk 1) | Recent organ-preservation strategies are shifting toward PD-1-based chemoimmunotherapy for locally advanced hypopharyngeal/laryngeal cancer, aiming to improve response and preserve laryngeal function without routine upfront total laryngectomy. | Gong/Wang, 2024-2023 (NCT04156698/NCT06039631) | https://clinicaltrials.gov/study/NCT04156698 ; https://clinicaltrials.gov/study/NCT06039631 |
Table: This table summarizes key recent evidence and quantitative findings relevant to postcricoid-region cancer within hypopharyngeal squamous cell carcinoma. It highlights epidemiology, diagnosis, outcomes, risk context, and emerging organ-preservation approaches.
The evidence here is largely from aggregated disease-level resources (GLOBOCAN 2020 analysis, imaging recommendations, trials) and cohort studies/case series, not single EHR-derived patient observations (mousavi2024globalepidemiologyand pages 1-2, sahu2023imagingrecommendationsfor pages 1-2, katano2024earlystagehypopharyngealsquamous pages 1-2).
Most postcricoid cancers are mucosal epithelial SCCs arising in the upper aerodigestive tract, consistent with the broader hypopharyngeal SCC pathogenesis (mousavi2024globalepidemiologyand pages 1-2, li2026novellaryngealpreservation pages 1-2).
Lifestyle/environmental: * Tobacco and alcohol are highlighted as major risk factors in imaging-based clinical guidance for larynx/hypopharynx cancers (sahu2023imagingrecommendationsfor pages 1-2).
Syndromic/premalignant association (important for the postcricoid region): Plummer–Vinson syndrome (PVS) * PVS is classically defined by the triad of iron deficiency anemia, post-cricoid dysphagia, and an upper esophageal/post-cricoid web, and is consistently described as associated with upper aerodigestive squamous cancers (patil2023endoscopicsubmucosaldissection pages 1-2, lo2019plummervinsonsyndromeimproving pages 1-2). * Quantitative risk ranges reported in retrieved sources: * “Malignancies occur at an incidence of 3–15%” in PVS (lo2019plummervinsonsyndromeimproving pages 2-3). * A pooled frequency range reported in one PVS-focused source indicates post-cricoid carcinoma occurs in ~4–16% across studies (patil2023endoscopicsubmucosaldissection pages 1-2).
Protective factors: not clearly identified in the retrieved evidence set for this specific subsite.
The strongest evidence in this set supports classic carcinogen exposure (tobacco/alcohol) and mucosal vulnerability due to iron deficiency (PVS) as converging pathways toward squamous carcinogenesis (sahu2023imagingrecommendationsfor pages 1-2, patil2023endoscopicsubmucosaldissection pages 2-4).
Common presenting features for larynx/hypopharynx cancers include hoarseness, breathing difficulty, dysphagia/odynophagia, foreign-body sensation, ear ache, and advanced presentations including stridor or aspiration (sahu2023imagingrecommendationsfor pages 1-2).
Early-stage hypopharyngeal SCC (including postcricoid) is often not detected promptly. One 2024 cohort reports: “HSCC is often undetected until advanced stages” and notes that “More than 50% of patients with hypopharyngeal cancers … present at an advanced stage.” (katano2024earlystagehypopharyngealsquamous pages 1-2).
Swallowing and voice/airway issues are intrinsic to hypopharyngeal/postcricoid tumors due to proximity to the larynx and esophageal inlet; contemporary organ-preservation trials explicitly include QoL instruments (e.g., EORTC QLQ-H&N35; MDADI; VHI-10) as endpoints (NCT06957938 chunk 2, NCT06039631 chunk 1).
(These are suggested mappings based on the symptom set described in the clinical literature above; the exact HPO identifiers were not explicitly provided in retrieved sources.)
Postcricoid cancers are usually SCC and share canonical head-and-neck SCC alterations.
From the retrieved HNSCC-focused reviews, major implicated signaling and cellular processes include: * Cell-cycle dysregulation / DNA damage response (TP53, CDKN2A/p16, RB1/CCND1 context) (shirima2024epithelial‑derivedheadand pages 3-4, afshari2023potentialalternativetherapeutic pages 1-2). * RTK/RAS and EGFR signaling (EGFR and RAS family contributions, therapeutic implications such as cetuximab resistance) (shirima2024epithelial‑derivedheadand pages 3-4). * PI3K/AKT/mTOR pathway and PTEN (shirima2024epithelial‑derivedheadand pages 3-4). * Squamous differentiation programs including NOTCH signaling (afshari2023potentialalternativetherapeutic pages 1-2). * Immune evasion/checkpoint biology (PD-1/PD-L1 axis relevance in SCC immunotherapy selection) (shirima2024epithelial‑derivedheadand pages 3-4).
(These are suggested mechanism mappings; explicit GO annotations were not provided in the retrieved sources.)
(Again, suggested mappings; CL identifiers are not explicitly stated in retrieved sources.)
HPV appears to be relevant to a subset of non-oropharyngeal SCCs, but postcricoid-specific HPV prevalence was not extracted from the current evidence set.
The broader HNSCC literature emphasizes immune checkpoint biology (PD-1/PD-L1) as both a therapeutic target and part of immune evasion programs. TP53 alterations may intersect with immune-related tumor behaviors, and immune checkpoint inhibition is central in contemporary organ-preservation trials for hypopharyngeal cancer (shirima2024epithelial‑derivedheadand pages 3-4, NCT04156698 chunk 1).
(UBERON IDs are provided as suggested ontology mappings; explicit UBERON annotations were not contained in the retrieved text.)
The Sahu 2023 imaging recommendations include CT figures of normal hypopharynx anatomy and imaging of postcricoid-region cancer, as well as TNM staging tables, supporting subsite localization and staging criteria (sahu2023imagingrecommendationsfor media 624946c3, sahu2023imagingrecommendationsfor media dd0e55cc, sahu2023imagingrecommendationsfor media 9d694104, sahu2023imagingrecommendationsfor media 0adf3cdb, sahu2023imagingrecommendationsfor media ea5671f7, sahu2023imagingrecommendationsfor media 2fc9a3ce).
Hypopharyngeal SCC commonly presents late; early disease may be subtle. In the 2024 early-stage HSCC radiotherapy cohort: “HSCC is often undetected until advanced stages” and “More than 50% of patients … present at an advanced stage” (katano2024earlystagehypopharyngealsquamous pages 1-2).
Staging follows AJCC TNM for hypopharyngeal SCC, with T descriptors incorporating extension/subsite involvement and invasion of structures including the cricoid cartilage (T4a) (sahu2023imagingrecommendationsfor pages 10-12).
A 2024 GLOBOCAN 2020 analysis reported: * 84,254 new cases globally in 2020; ASIR 0.91 per 100,000. * 38,599 deaths in 2020; ASMR 0.41 per 100,000. * MIR 0.45. * Projected increases by 2040: +50% new cases and +55% deaths (mousavi2024globalepidemiologyand pages 1-2).
Subsite distribution of hypopharyngeal cancer reported in the same source: ~70% pyriform sinus, ~25% posterior pharyngeal wall, remainder largely post-cricoid (mousavi2024globalepidemiologyand pages 1-2).
Hypopharyngeal cancer shows higher incidence/mortality in men than women and increases with age (notably ≥70 years) (mousavi2024globalepidemiologyand pages 1-2, mousavi2024globalepidemiologyand pages 2-3).
Imaging recommendations emphasize that endoscopy is essential for mucosal assessment but is insufficient for complete staging because submucosal and deep-space spread can be missed.
NCCN-referenced diagnostic workup items (as quoted/compiled in Sahu 2023): * “examination under anesthesia with endoscopy” * “CECT and/ or MRI for primary and neck” * “Chest CT … for advanced nodal disease” * “FDG PET-CT … for stage III-IV disease” (sahu2023imagingrecommendationsfor pages 1-2)
Postcricoid-specific imaging note: post-cricoid hypopharyngeal carcinoma is described as uncommon and “often shows submucosal spread toward the cervical esophagus,” with MRI better delineating extent (sahu2023imagingrecommendationsfor pages 5-8).
Squamous cell carcinoma is the predominant histology in hypopharyngeal cancer (mousavi2024globalepidemiologyand pages 1-2, li2026novellaryngealpreservation pages 1-2).
PD-1/PD-L1 axis is clinically actionable in HNSCC broadly and is integral to the modern immunotherapy-based organ-preservation strategies tested in hypopharyngeal cancer trials (NCT04156698 chunk 1, NCT06039631 chunk 1).
Sahu 2023 notes non-squamous malignant lesions are rare and often submucosal; a full differential diagnosis list was not extracted in the current evidence set (sahu2023imagingrecommendationsfor pages 1-2).
Performance status (ECOG PS) was an independent OS risk factor in the early-stage RT cohort (HR 8.457) (katano2024earlystagehypopharyngealsquamous pages 1-2).
Early stage: single-modality RT or surgery; a uniform definitive RT approach of 70 Gy/35 fractions with elective nodal irradiation is feasible with low high-grade toxicity in one modern series (katano2024earlystagehypopharyngealsquamous pages 1-2).
Advanced disease: multimodality management. Imaging recommendations summarize: “Early stage disease is treated with single modalities such as radiotherapy or surgery. Advanced disease is treated with multimodality of either chemoradiotherapy or surgery followed by adjuvant radiotherapy with or without concurrent chemotherapy.” (sahu2023imagingrecommendationsfor pages 1-2).
A retrospective cohort comparing surgery-based therapy (SBT) vs definitive chemoradiotherapy (CRT) found significantly better survival with SBT overall; however, for some subgroups (e.g., T3/stage III) survival differences were less pronounced (lin2023survivalanalysesof pages 1-2).
Key 2024 phase II trial (directly in hypopharyngeal SCC): * Nature Communications 2024 reports: “This phase II trial aimed to determine the efficacy and safety of induction chemoimmunotherapy of camrelizumab plus modified TPF in locally advanced hypopharyngeal squamous cell carcinoma (LA HSCC) (NCT04156698).” It reports ORR 82.4% and interim 2-year OS/PFS/LPR outcomes: 2-year OS 83.0%, PFS 77.1%, larynx preservation rate 70.0% (sahu2023imagingrecommendationsfor media ea5671f7, NCT04156698 chunk 1).
Ongoing 2023-start randomized phase II organ-preservation strategy (larynx/hypopharynx): * NCT06039631 (Fudan University; recruiting; start Aug 22, 2023) randomizes post-neoadjuvant chemoimmunotherapy patients to organ-preservation surgery vs concurrent chemoradiation (RT 70 Gy/35 fractions plus weekly cisplatin in one arm), with adjuvant toripalimab; primary endpoint is 2-year PFS and key secondary endpoints include larynx preservation rate and QoL (MDADI, VHI-10) (NCT06039631 chunk 1).
(MAXO IDs are suggested; the retrieved sources do not contain explicit MAXO mappings.)
Risk-factor modification (tobacco/alcohol reduction) is implied by the strong risk-factor association described in clinical guidance (sahu2023imagingrecommendationsfor pages 1-2).
Plummer–Vinson syndrome is consistently described as carrying malignancy risk that warrants surveillance: * PVS review abstract: “the risk of malignancy warrants long-term surveillance” (lo2019plummervinsonsyndromeimproving pages 1-2). * A PVS-focused excerpt notes “Surveillance endoscopy can be performed yearly, though no definitive recommendation exists” (patil2023endoscopicsubmucosaldissection pages 2-4).
No naturally occurring postcricoid-region cancer analogs in other species were identified in the retrieved evidence set.
No postcricoid-region–specific experimental animal models were identified in the retrieved evidence set; mechanistic studies are therefore typically extrapolated from broader HNSCC models (cell lines, xenografts/PDX), but this is a current evidence gap in this retrieval (afshari2023potentialalternativetherapeutic pages 1-2).
References
(glastonbury2020headandneck pages 1-2): Christine M. Glastonbury. Head and neck squamous cell cancer: approach to staging and surveillance. IDKD Springer Series, pages 215-222, Feb 2020. URL: https://doi.org/10.1007/978-3-030-38490-6_17, doi:10.1007/978-3-030-38490-6_17. This article has 46 citations.
(mousavi2024globalepidemiologyand pages 1-2): Seyed Ehsan Mousavi, Mehran Ilaghi, Yasaman Mirzazadeh, Alireza Mosavi Jarrahi, and Seyed Aria Nejadghaderi. Global epidemiology and socioeconomic correlates of hypopharyngeal cancer in 2020 and its projection to 2040: findings from globocan 2020. Frontiers in Oncology, Sep 2024. URL: https://doi.org/10.3389/fonc.2024.1398063, doi:10.3389/fonc.2024.1398063. This article has 13 citations.
(sahu2023imagingrecommendationsfor pages 5-8): Arpita Sahu, Abhishek Mahajan, Delnaz Palsetia, Richa Vaish, Sarbani Ghosh Laskar, Jyoti Kumar, Namita Kamath, Ashu Seith Bhalla, Diva Shah, Amit Sahu, Ujjwal Agarwal, Aditi Venkatesh, Suman Kumar Ankathi, Amit Janu, Vasundhara Patil, Tejas H. Kapadia, Munita Bal, Shwetabh Sinha, Kumar Prabhash, and A. K. Dcruz. Imaging recommendations for diagnosis, staging and management of larynx and hypopharynx cancer. Indian Journal of Medical and Paediatric Oncology, 44:054-065, Jan 2023. URL: https://doi.org/10.1055/s-0042-1759504, doi:10.1055/s-0042-1759504. This article has 15 citations.
(katano2024earlystagehypopharyngealsquamous pages 1-2): Atsuto Katano and Hideomi Yamashita. Early-stage hypopharyngeal squamous cell carcinoma treated with radical radiotherapy at a uniform dose of 70 gy in 35 fractions: a single-center study. European Archives of Oto-Rhino-Laryngology, 281:4401-4407, May 2024. URL: https://doi.org/10.1007/s00405-024-08722-w, doi:10.1007/s00405-024-08722-w. This article has 11 citations and is from a peer-reviewed journal.
(mousavi2024globalepidemiologyand pages 2-3): Seyed Ehsan Mousavi, Mehran Ilaghi, Yasaman Mirzazadeh, Alireza Mosavi Jarrahi, and Seyed Aria Nejadghaderi. Global epidemiology and socioeconomic correlates of hypopharyngeal cancer in 2020 and its projection to 2040: findings from globocan 2020. Frontiers in Oncology, Sep 2024. URL: https://doi.org/10.3389/fonc.2024.1398063, doi:10.3389/fonc.2024.1398063. This article has 13 citations.
(sahu2023imagingrecommendationsfor pages 1-2): Arpita Sahu, Abhishek Mahajan, Delnaz Palsetia, Richa Vaish, Sarbani Ghosh Laskar, Jyoti Kumar, Namita Kamath, Ashu Seith Bhalla, Diva Shah, Amit Sahu, Ujjwal Agarwal, Aditi Venkatesh, Suman Kumar Ankathi, Amit Janu, Vasundhara Patil, Tejas H. Kapadia, Munita Bal, Shwetabh Sinha, Kumar Prabhash, and A. K. Dcruz. Imaging recommendations for diagnosis, staging and management of larynx and hypopharynx cancer. Indian Journal of Medical and Paediatric Oncology, 44:054-065, Jan 2023. URL: https://doi.org/10.1055/s-0042-1759504, doi:10.1055/s-0042-1759504. This article has 15 citations.
(sahu2023imagingrecommendationsfor pages 2-3): Arpita Sahu, Abhishek Mahajan, Delnaz Palsetia, Richa Vaish, Sarbani Ghosh Laskar, Jyoti Kumar, Namita Kamath, Ashu Seith Bhalla, Diva Shah, Amit Sahu, Ujjwal Agarwal, Aditi Venkatesh, Suman Kumar Ankathi, Amit Janu, Vasundhara Patil, Tejas H. Kapadia, Munita Bal, Shwetabh Sinha, Kumar Prabhash, and A. K. Dcruz. Imaging recommendations for diagnosis, staging and management of larynx and hypopharynx cancer. Indian Journal of Medical and Paediatric Oncology, 44:054-065, Jan 2023. URL: https://doi.org/10.1055/s-0042-1759504, doi:10.1055/s-0042-1759504. This article has 15 citations.
(katano2024earlystagehypopharyngealsquamous pages 2-5): Atsuto Katano and Hideomi Yamashita. Early-stage hypopharyngeal squamous cell carcinoma treated with radical radiotherapy at a uniform dose of 70 gy in 35 fractions: a single-center study. European Archives of Oto-Rhino-Laryngology, 281:4401-4407, May 2024. URL: https://doi.org/10.1007/s00405-024-08722-w, doi:10.1007/s00405-024-08722-w. This article has 11 citations and is from a peer-reviewed journal.
(lin2023survivalanalysesof pages 1-2): Tian-Yun Lin, Tsung-Lun Lee, Yen-Bin Hsu, Shyh-Kuan Tai, Ling-Wei Wang, Muh-Hwa Yang, and Pen-Yuan Chu. Survival analyses of different treatment modalities and clinical stage for hypopharyngeal carcinoma. Frontiers in Oncology, Mar 2023. URL: https://doi.org/10.3389/fonc.2023.1109417, doi:10.3389/fonc.2023.1109417. This article has 10 citations.
(lin2023survivalanalysesof pages 2-3): Tian-Yun Lin, Tsung-Lun Lee, Yen-Bin Hsu, Shyh-Kuan Tai, Ling-Wei Wang, Muh-Hwa Yang, and Pen-Yuan Chu. Survival analyses of different treatment modalities and clinical stage for hypopharyngeal carcinoma. Frontiers in Oncology, Mar 2023. URL: https://doi.org/10.3389/fonc.2023.1109417, doi:10.3389/fonc.2023.1109417. This article has 10 citations.
(patil2023endoscopicsubmucosaldissection pages 1-2): Gaurav Patil, Amol Vadgaonkar, Ankit Dalal, Sanil Parekh, Animesh Shah, Poorva Haridas, Prajakta Gupte, Sehajad Vora, and Amit Maydeo. Endoscopic submucosal dissection for esophageal squamous cell high-grade dysplasia in a patient with plummer vinson syndrome. Journal of Digestive Endoscopy, 14:051-055, Dec 2023. URL: https://doi.org/10.1055/s-0042-1759510, doi:10.1055/s-0042-1759510. This article has 1 citations.
(lo2019plummervinsonsyndromeimproving pages 5-6): Kevin Bryan Lo, Jeri Albano, Naemat Sandhu, and Nellowe Candelario. Plummer-vinson syndrome: improving outcomes with a multidisciplinary approach. Journal of Multidisciplinary Healthcare, 12:471-477, Jun 2019. URL: https://doi.org/10.2147/jmdh.s180410, doi:10.2147/jmdh.s180410. This article has 35 citations and is from a peer-reviewed journal.
(patil2023endoscopicsubmucosaldissection pages 2-4): Gaurav Patil, Amol Vadgaonkar, Ankit Dalal, Sanil Parekh, Animesh Shah, Poorva Haridas, Prajakta Gupte, Sehajad Vora, and Amit Maydeo. Endoscopic submucosal dissection for esophageal squamous cell high-grade dysplasia in a patient with plummer vinson syndrome. Journal of Digestive Endoscopy, 14:051-055, Dec 2023. URL: https://doi.org/10.1055/s-0042-1759510, doi:10.1055/s-0042-1759510. This article has 1 citations.
(lo2019plummervinsonsyndromeimproving pages 2-3): Kevin Bryan Lo, Jeri Albano, Naemat Sandhu, and Nellowe Candelario. Plummer-vinson syndrome: improving outcomes with a multidisciplinary approach. Journal of Multidisciplinary Healthcare, 12:471-477, Jun 2019. URL: https://doi.org/10.2147/jmdh.s180410, doi:10.2147/jmdh.s180410. This article has 35 citations and is from a peer-reviewed journal.
(NCT04156698 chunk 1): Induction Chemotherapy Combined With Immunotherapy for Locally Advanced Hypopharyngeal Carcinoma. Eye & ENT Hospital of Fudan University. 2020. ClinicalTrials.gov Identifier: NCT04156698
(NCT06039631 chunk 1): Yu Wang. Neoadjuvant Chemoimmunotherapy Followed By Radiation Or Organ Preservation Surgery In Laryngeal/Hypopharyngeal Cancer. Fudan University. 2023. ClinicalTrials.gov Identifier: NCT06039631
(OpenTargets Search: hypopharyngeal carcinoma,head and neck squamous cell carcinoma): Open Targets Query (hypopharyngeal carcinoma,head and neck squamous cell carcinoma, 13 results). Buniello, A. et al. (2025). Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery. Nucleic Acids Research.
(li2026novellaryngealpreservation pages 1-2): Xuexin Li, Xiaoran Zhang, Yun Lin, Yan Ma, Zheng Jiang, Dapeng Lei, Xinliang Pan, and Jun Liu. Novel laryngeal preservation technique in postcricoid hypopharyngeal carcinoma: a case-series study. BMC Surgery, Mar 2026. URL: https://doi.org/10.1186/s12893-026-03586-9, doi:10.1186/s12893-026-03586-9. This article has 0 citations and is from a peer-reviewed journal.
(lo2019plummervinsonsyndromeimproving pages 1-2): Kevin Bryan Lo, Jeri Albano, Naemat Sandhu, and Nellowe Candelario. Plummer-vinson syndrome: improving outcomes with a multidisciplinary approach. Journal of Multidisciplinary Healthcare, 12:471-477, Jun 2019. URL: https://doi.org/10.2147/jmdh.s180410, doi:10.2147/jmdh.s180410. This article has 35 citations and is from a peer-reviewed journal.
(NCT06957938 chunk 2): Yu Wang. Comparing Neoadjuvant Chemotherapy Combined With PD-1 Inhibitor Versus Neoadjuvant Chemotherapy in Locally Advanced Laryngeal and Hypopharyngeal Carcinoma. Fudan University. 2025. ClinicalTrials.gov Identifier: NCT06957938
(shirima2024epithelial‑derivedheadand pages 3-4): Charles Shirima, Coralia Bleotu, Demetrios Spandidos, Adel El‑Naggar, Gratiela Gradisteanu Pircalabioru, and Ioannis Michalopoulos. Epithelial‑derived head and neck squamous tumourigenesis (review). Oncology Reports, Aug 2024. URL: https://doi.org/10.3892/or.2024.8800, doi:10.3892/or.2024.8800. This article has 12 citations and is from a peer-reviewed journal.
(afshari2023potentialalternativetherapeutic pages 1-2): Keihan Afshari and Karpal Singh Sohal. Potential alternative therapeutic modalities for management head and neck squamous cell carcinoma: a review. Cancer Control : Journal of the Moffitt Cancer Center, Apr 2023. URL: https://doi.org/10.1177/10732748231185003, doi:10.1177/10732748231185003. This article has 13 citations.
(sahu2023imagingrecommendationsfor media 624946c3): Arpita Sahu, Abhishek Mahajan, Delnaz Palsetia, Richa Vaish, Sarbani Ghosh Laskar, Jyoti Kumar, Namita Kamath, Ashu Seith Bhalla, Diva Shah, Amit Sahu, Ujjwal Agarwal, Aditi Venkatesh, Suman Kumar Ankathi, Amit Janu, Vasundhara Patil, Tejas H. Kapadia, Munita Bal, Shwetabh Sinha, Kumar Prabhash, and A. K. Dcruz. Imaging recommendations for diagnosis, staging and management of larynx and hypopharynx cancer. Indian Journal of Medical and Paediatric Oncology, 44:054-065, Jan 2023. URL: https://doi.org/10.1055/s-0042-1759504, doi:10.1055/s-0042-1759504. This article has 15 citations.
(sahu2023imagingrecommendationsfor media dd0e55cc): Arpita Sahu, Abhishek Mahajan, Delnaz Palsetia, Richa Vaish, Sarbani Ghosh Laskar, Jyoti Kumar, Namita Kamath, Ashu Seith Bhalla, Diva Shah, Amit Sahu, Ujjwal Agarwal, Aditi Venkatesh, Suman Kumar Ankathi, Amit Janu, Vasundhara Patil, Tejas H. Kapadia, Munita Bal, Shwetabh Sinha, Kumar Prabhash, and A. K. Dcruz. Imaging recommendations for diagnosis, staging and management of larynx and hypopharynx cancer. Indian Journal of Medical and Paediatric Oncology, 44:054-065, Jan 2023. URL: https://doi.org/10.1055/s-0042-1759504, doi:10.1055/s-0042-1759504. This article has 15 citations.
(sahu2023imagingrecommendationsfor media 9d694104): Arpita Sahu, Abhishek Mahajan, Delnaz Palsetia, Richa Vaish, Sarbani Ghosh Laskar, Jyoti Kumar, Namita Kamath, Ashu Seith Bhalla, Diva Shah, Amit Sahu, Ujjwal Agarwal, Aditi Venkatesh, Suman Kumar Ankathi, Amit Janu, Vasundhara Patil, Tejas H. Kapadia, Munita Bal, Shwetabh Sinha, Kumar Prabhash, and A. K. Dcruz. Imaging recommendations for diagnosis, staging and management of larynx and hypopharynx cancer. Indian Journal of Medical and Paediatric Oncology, 44:054-065, Jan 2023. URL: https://doi.org/10.1055/s-0042-1759504, doi:10.1055/s-0042-1759504. This article has 15 citations.
(sahu2023imagingrecommendationsfor media 0adf3cdb): Arpita Sahu, Abhishek Mahajan, Delnaz Palsetia, Richa Vaish, Sarbani Ghosh Laskar, Jyoti Kumar, Namita Kamath, Ashu Seith Bhalla, Diva Shah, Amit Sahu, Ujjwal Agarwal, Aditi Venkatesh, Suman Kumar Ankathi, Amit Janu, Vasundhara Patil, Tejas H. Kapadia, Munita Bal, Shwetabh Sinha, Kumar Prabhash, and A. K. Dcruz. Imaging recommendations for diagnosis, staging and management of larynx and hypopharynx cancer. Indian Journal of Medical and Paediatric Oncology, 44:054-065, Jan 2023. URL: https://doi.org/10.1055/s-0042-1759504, doi:10.1055/s-0042-1759504. This article has 15 citations.
(sahu2023imagingrecommendationsfor media ea5671f7): Arpita Sahu, Abhishek Mahajan, Delnaz Palsetia, Richa Vaish, Sarbani Ghosh Laskar, Jyoti Kumar, Namita Kamath, Ashu Seith Bhalla, Diva Shah, Amit Sahu, Ujjwal Agarwal, Aditi Venkatesh, Suman Kumar Ankathi, Amit Janu, Vasundhara Patil, Tejas H. Kapadia, Munita Bal, Shwetabh Sinha, Kumar Prabhash, and A. K. Dcruz. Imaging recommendations for diagnosis, staging and management of larynx and hypopharynx cancer. Indian Journal of Medical and Paediatric Oncology, 44:054-065, Jan 2023. URL: https://doi.org/10.1055/s-0042-1759504, doi:10.1055/s-0042-1759504. This article has 15 citations.
(sahu2023imagingrecommendationsfor media 2fc9a3ce): Arpita Sahu, Abhishek Mahajan, Delnaz Palsetia, Richa Vaish, Sarbani Ghosh Laskar, Jyoti Kumar, Namita Kamath, Ashu Seith Bhalla, Diva Shah, Amit Sahu, Ujjwal Agarwal, Aditi Venkatesh, Suman Kumar Ankathi, Amit Janu, Vasundhara Patil, Tejas H. Kapadia, Munita Bal, Shwetabh Sinha, Kumar Prabhash, and A. K. Dcruz. Imaging recommendations for diagnosis, staging and management of larynx and hypopharynx cancer. Indian Journal of Medical and Paediatric Oncology, 44:054-065, Jan 2023. URL: https://doi.org/10.1055/s-0042-1759504, doi:10.1055/s-0042-1759504. This article has 15 citations.
(sahu2023imagingrecommendationsfor pages 10-12): Arpita Sahu, Abhishek Mahajan, Delnaz Palsetia, Richa Vaish, Sarbani Ghosh Laskar, Jyoti Kumar, Namita Kamath, Ashu Seith Bhalla, Diva Shah, Amit Sahu, Ujjwal Agarwal, Aditi Venkatesh, Suman Kumar Ankathi, Amit Janu, Vasundhara Patil, Tejas H. Kapadia, Munita Bal, Shwetabh Sinha, Kumar Prabhash, and A. K. Dcruz. Imaging recommendations for diagnosis, staging and management of larynx and hypopharynx cancer. Indian Journal of Medical and Paediatric Oncology, 44:054-065, Jan 2023. URL: https://doi.org/10.1055/s-0042-1759504, doi:10.1055/s-0042-1759504. This article has 15 citations.